CS logo
small CS logo
RM Gorbacheva Research Institute

Saint Petersburg, Russian Federation
Higher educational institution in Saint Petersburg
Ulitsa L'va Tolstogo, 6-8, St Petersburg, 197022

About RM Gorbacheva Research Institute


The First Pavlov State Medical University of St. Petersburg is a higher education institution, medical university in St. Petersburg. PSPbGMU is called the First Medical Institute in St. Petersburg because of its renaming in 1936, relative to Saint Petersburg State Medical Academy named after I.I.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
St. Petersburg State Pavlov Medical University
4
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
3
Pfizer
2
National Research Center for Hematology, Russia
1
Total Rows: 4

Clinical Trials at RM Gorbacheva Research Institute


During the past decade, RM Gorbacheva Research Institute conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years113333000000Started TrialsCompleted Trails20192020202101234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
2011-03-01
2018-06-01
Completed
101
A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy
2011-04-04
2014-03-28
Terminated
338
Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008
2008-02-01
2020-07-01
Unknown status
3,000
Brentuximab Vedotin as Alternative to the Autologous Stem Cell Transplantation in Relapsed and Refractory Classical Hodgkin's Lymphoma (BASALT)
2019-05-14
2023-12-02
Recruiting
80
Registry of Patients With Hematologic Disease and COVID-19 in Russia
2020-06-22
2022-01-18
Completed
666
Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Before Hematopoietic Stem Cell Transplantation (HSCT)
2020-12-15
2023-09-01
Not yet recruiting
15
PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT
2020-11-03
2025-02-01
Active, not recruiting
128
Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)
2021-01-21
2024-12-31
Recruiting
40

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "RM Gorbacheva Research Institute" #1 collaborator was "Enrollme.ru, LLC" with 1 trials as a collaborator, "Foundation for Cancer Research Support (RakFond)" with 1 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsSt. Petersburg StatePavlov MedicalUniversity: 4St. Petersburg StatePavlov MedicalUniversity: 4Federal ResearchInstitute of PediatricHematology, Oncologyand Immunology: 3Federal ResearchInstitute of PediatricHematology, Oncologyand Immunology: 3Pfizer: 2Pfizer: 2National ResearchCenter for Hematology,Russia: 1National ResearchCenter for Hematology,Russia: 1

Created with Highcharts 11.1.0Top CollaboratorsEnrollme.ru, LLC: 1Enrollme.ru, LLC: 1Foundation for CancerResearch Support(RakFond): 1Foundation for CancerResearch Support(RakFond): 1UCB Pharma: 1UCB Pharma: 1

Clinical Trials Conditions at RM Gorbacheva Research Institute


According to Clinical.Site data, the most researched conditions in "RM Gorbacheva Research Institute" are "Myelodysplastic Syndromes" (2 trials), "Myeloid Leukemia, Acute" (2 trials), "Myeloproliferative Neoplasm" (2 trials), "Acute Lymphoid Leukemia" (1 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "RM Gorbacheva Research Institute" in a lesser frequency.

Clinical Trials Intervention Types at RM Gorbacheva Research Institute


Most popular intervention types in "RM Gorbacheva Research Institute" are "Drug" (7 trials), "Other" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bendamustine Hydrochloride" (2 trials), "Mycophenolate Mofetil" (2 trials), "Brentuximab Vedotin" (1 trials), "Busulfan" (1 trials) and "Cranial irradiation" (1 trials). Other intervention names were less common.

Clinical Trials Genders at RM Gorbacheva Research Institute


The vast majority of trials in "RM Gorbacheva Research Institute" are 10 trials for "All" genders.

Clinical Trials Status at RM Gorbacheva Research Institute


Currently, there are NaN active trials in "RM Gorbacheva Research Institute". 1 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in RM Gorbacheva Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in RM Gorbacheva Research Institute, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 6Phase 2: 6Not Applicable: 1Not Applicable: 1Phase 1: 1Phase 1: 1Phase 3: 1Phase 3: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 4Recruiting: 4Completed: 2Completed: 2Active, not recruiting: 1Active, not recruiting: 1Not yet recruiting: 1Not yet recruiting: 1Terminated: 1Terminated: 1Unknown status: 1Unknown status: 1